Frequent loss of the second allele in combination with biallelic loss of NF2 has been reported in such tumor tissues, indicating that SMARCB1 acts as a tumor suppressor in schwannomas and that the familial SMARCB1 mutations lead to a loss-of-function. The gene discussed is SMARCB1; the disease is schwannoma.